We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Steris
STE
$23.1B
| $434K | ﹤0.01% |
+1,712
| New | +$430K |
|
2527
CALL
ResMed
RMD
$32.8B
| $434K | ﹤0.01% |
1,800
-6,400
| -78% | -$1.64M |
|
2528
Atmos Energy
ATO
$28.7B
| $433K | ﹤0.01% |
2,583
+147
| +6% | +$25.4K |
|
2529
PUT
Astera Labs
ALAB
$55.3B
| $433K | ﹤0.01% |
2,600
-21,000
| -89% | -$3.51M |
|
2530
Zeta Global
ZETA
$7.17B
| $432K | ﹤0.01% |
21,231
-126,302
| -86% | -$2.36M |
|
2531
Customers Bancorp
CUBI
$2.8B
| $431K | ﹤0.01% |
5,898
-152,531
| -96% | -$10.5M |
|
2532
ASP Isotopes
ASPI
$541M
| $431K | ﹤0.01% |
80,527
+37,639
| +88% | +$299K |
|
2533
FB Financial Corp
FBK
$3.1B
| $430K | ﹤0.01% |
7,701
+3,158
| +70% | +$177K |
|
2534
PUT
Cheniere Energy
LNG
$55.4B
| $428K | ﹤0.01% |
+2,200
| New | +$462K |
|
2535
CoStar Group
CSGP
$12.4B
| $427K | ﹤0.01% |
+6,343
| New | +$449K |
|
2536
Ingersoll Rand
IR
$32.9B
| $426K | ﹤0.01% |
5,381
+1,362
| +34% | +$108K |
|
|
VG
2537
Venture Global Inc
VG
$34.3B
| $424K | ﹤0.01% |
62,213
-542,637
| -90% | -$4.52M |
|
2538
Vericel Corp
VCEL
$2.29B
| $424K | ﹤0.01% |
+11,780
| New | +$433K |
|
2539
CMS Energy
CMS
$22B
| $422K | ﹤0.01% |
+6,041
| New | +$439K |
|
2540
Shell
SHEL
$249B
| $421K | ﹤0.01% |
5,727
-6,131
| -52% | -$452K |
|
2541
Stagwell
STGW
$2.29B
| $420K | ﹤0.01% |
85,955
+18,602
| +28% | +$96.8K |
|
2542
REX American Resources
REX
$1.44B
| $420K | ﹤0.01% |
13,001
+4,744
| +57% | +$155K |
|
2543
CALL
Amphenol
APH
$210B
| $419K | ﹤0.01% |
+3,100
| New | +$415K |
|
2544
Clear Channel Outdoor Holdings
CCO
$1.23B
| $418K | ﹤0.01% |
189,256
+134,112
| +243% | +$249K |
|
2545
Archer Daniels Midland
ADM
$38.4B
| $417K | ﹤0.01% |
7,261
-3,646
| -33% | -$218K |
|
2546
Veralto
VLTO
$23.6B
| $417K | ﹤0.01% |
4,175
-311,687
| -99% | -$31.5M |
|
2547
PUT
GeneDx Holdings
WGS
$2.46B
| $416K | ﹤0.01% |
3,200
-4,700
| -59% | -$645K |
|
2548
Antero Midstream
AM
$10.6B
| $413K | ﹤0.01% |
23,197
-4,868
| -17% | -$87.7K |
|
2549
Canadian Natural Resources
CNQ
$98.1B
| $413K | ﹤0.01% |
12,181
-19,685
| -62% | -$638K |
|
2550
Boston Beer
SAM
$1.89B
| $411K | ﹤0.01% |
2,105
+800
| +61% | +$165K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.